Showing results (81-90 of 280) with videos related to
Sort By:
Pageof 28
The Journal of Clinical Investigation|November 1, 1994
Antioxidant: a new role for RU-486 and related compoundsS Parthasarathy, A J Morales, A A MurphyJournal of Clinical and Diagnostic Research : JCDR|February 2, 2013
Transient hypertension after an interscalene block-the presentation of a rare complication with an anatomical explanationSameer Mahamud Jahagirdar, C Rajesh Prabhu, S ParthasarathyBiochimica Et Biophysica Acta|April 27, 1979
Ethanediol monoester hydrolysis by monoacylglycerol lipase of rat liver microsomesS Parthasarathy, J T Lin, W J BaumannAtherosclerosis|April 27, 1999
Demonstration of the presence of lipid peroxide-modified proteins in human atherosclerotic lesions using a novel lipid peroxide-modified anti-peptide antibodyJ G Kim, W R Taylor, S ParthasarathyBiochimica Et Biophysica Acta|August 24, 1981
Modulation of phosphatidylcholine synthesis in vitro. Inhibition of diacylglycerol cholinephosphotransferase and lysophosphatidylcholine acyltransferase by centrophenoxine and neophenoxineS Parthasarathy, A El-Rahman, W J BaumannJournal of Lipid Research|September 1, 1993
Radioiodination of low density lipoprotein initiates lipid peroxidation: protection by use of antioxidantsA S Khouw, S Parthasarathy, J L WitztumIndian Journal of Anaesthesia|August 29, 2013
Comparative evaluation of gum-elastic bougie and introducer tool as aids in positioning of ProSeal laryngeal mask airway in patients with simulated restricted neck mobilityJennyl Maclean, Dk Tripathy, S Parthasarathy, et al.Journal of Lipid Research|April 29, 1998
Generation and initial characterization of a novel polyclonal antibody directed against homocysteine thiolactone-modified low density lipoproteinE Ferguson, S Parthasarathy, J Joseph, et al.Indian Journal of Anaesthesia|July 20, 2010
Ketamine and pulmonary oedema-report of two casesS Parthasarathy, M Ravishankar, S Selvarajan, et al.Atherosclerosis|April 6, 2004
A novel alkaloid antioxidant, Boldine and synthetic antioxidant, reduced form of RU486, inhibit the oxidation of LDL in-vitro and atherosclerosis in vivo in LDLR(-/-) miceN Santanam, M Penumetcha, H Speisky, et al.Pageof 28